HPLC Collaboration

Article

BAC BV, a Dutch provider of antibody-based affinity purification technology, has announced a strategic collaboration with Life Technologies, a manufacturer of molecular diagnostic and research-use products, which will bring the range of BAC's CaptureSelect affinity ligand specificities to Life Technologies' Poros chromatography media and pre-packed HPLC columns.

BAC BV, a Dutch provider of antibody-based affinity purification technology, has announced a strategic collaboration with Life Technologies, a manufacturer of molecular diagnostic and research-use products, which will bring the range of BAC's CaptureSelect affinity ligand specificities to Life Technologies' POROS chromatography media and pre-packed HPLC columns. According to the company this suite of products will provide a range of specificities and column formats for applications from discovery through to process monitoring.

"We are very excited to be able to provide a continuously evolving range of specificities and column formats that will allow more researchers to access the benefits of CaptureSelect technology", commented Laurens Sierkstra, CEO of BAC. "Scientists will be able to routinely use CaptureSelect ligands in formats that support QbD approaches for process development and monitoring."

The companies report that the collaboration will create a range of ready-to-use HPLC columns pre-packed with CaptureSelect affinity ligands immobilized on POROS chromatography media. Designed for the high pressures and flow-rates necessary to provide the real-time results for biopharmaceutical quality assurance needs, the companies claim that the selectivity of these columns will support Process Analytical Technology for almost any biopharmaceutical manufacturing process.

For more information about the company, visit their website at www.bacbv.com

Related Videos
Toby Astill | Image Credit: © Thermo Fisher Scientific
Robert Kennedy